candidates, especially those with preclinical evidence supporting their efficacy, like kaempferol and pramocaine, is warranted to understand their mechanisms of action and effectiveness in treating BD. Additionally, novel targets such as PARP1 and A2b offer opportunities for future research on their relevance to the disorder.
ReferencesDrugs and Lactation Database (LactMed) - About Dietary SupplementsBreastfeeding LinksRelated informationPubChem SubstancePubMedSimilar articles in PubMedReview Allergic Contact Dermatitis to Pramoxine (Pramocaine).[Dermatitis. 2021][Local anesthetic activity of pramoxine hydrochloride (tronothane)].[Anesth Analg (Paris). 1957]Review Dyclonine.[Drugs and Lactation Database (...]Contact allergy to pramoxine (pramocaine): the importance of testing to personal products.[Dermatitis. 2014]Tronothane hydrochloride (pramoxine hydrochloride) in the control of pruritus.[Postgrad Med. 1954]See reviews...See all...Recent ActivityClearTurn OffPramoxine - Drugs and Lactation Database (LactMed®)See more...FOLLOW NCBIConnect with NLM National Library of Medicine8600 Rockville PikeBethesda, MD 20894Web